Required section · Section 3 of 6
Common look-alikes and bounded methods
EDTA-dependent pseudothrombocytopenia is an in vitro, anticoagulant-dependent phenomenon. It does not itself establish a bleeding disorder, and it can develop with time after collection. A fresh EDTA tube and an alternate-anticoagulant tube may be needed in parallel when local procedure calls for them. Before changing method, inspect for a visible clot, confirm tube type and fill, ask whether the sample was diluted or delayed, record collection and analysis times, and compare a dated prior result only within its stated method and specimen limits.
Citrate is one alternate-anticoagulant example, not a universal cure for clumping: platelet aggregates can persist in citrate, and some patients have multi-anticoagulant-dependent clumping. Citrate collection also introduces dilution, and a short-filled citrate tube introduces additional preanalytical error. Keep three values distinct: the instrument's raw citrate count; any local, validated adjustment only after tube fill, specimen age, method, and correction criteria are met; and the final reportable result and comment authorized by that procedure. Do not apply a universal multiplier. If citrate remains clumped or is not suitable, any further alternate anticoagulant or method must be selected and released under the local validated procedure. Optical or fluorescence platelet channels can improve separation from size-related interference, but they do not make a clumped specimen reliable merely by producing a number.
Large or giant platelets can exceed an impedance platelet gate and cause undercounting. In contrast, fragments and very small red cells may overlap the impedance gate and falsely increase the platelet count. A manual chamber count or smear-based manual estimate has method-inherent imprecision at low platelet numbers and is not a universal replacement for a validated automated result; use it only when your laboratory has validated it for the specific interference and reportable range. If true thrombocytopenia remains after analytical causes are addressed, morphology may guide the next laboratory discussion without assigning a diagnosis. Choose the method your laboratory has validated for the specific interference, not the method that merely produces a larger number.
| Finding | Potential effect | Evidence to establish | Validated resolution | Release limitation |
|---|---|---|---|---|
| EDTA platelet aggregates | Falsely low or unreliable count | Smear, including lateral and feathered edges; tube and analyzer evidence | Prompt fresh draw and validated alternate-anticoagulant or method pathway | Do not release the clumped EDTA count as reliable |
| Citrate-persistent or multi-anticoagulant aggregates | Falsely low or unreliable count despite alternate collection | Repeat smear from each specimen and document whether clumps persist | Use only a further locally validated alternate specimen or method; seek qualified review when unresolved | Citrate does not prove reliability or resolve every clumping pattern |
| Citrate dilution or inadequate citrate fill | Count may be biased by dilution or collection error | Confirm tube type, fill, handling, and local correction criteria | Recollect or apply only the laboratory-validated citrate process | Never use a universal citrate multiplier |
| Platelet satellitism | Automated undercount | Platelets adherent around neutrophils on smear | Follow the locally validated resolution path | Do not infer a numeric correction from the smear |
| Giant platelets | Impedance undercount | Smear morphology and method-specific analyzer evidence | Consider a validated optical, fluorescence, or manual chamber counting method matched to the interference | Release only a method demonstrated suitable for the specimen |
| RBC fragments or very small RBCs | Impedance false increase | Histogram and smear correlation | Use a validated method with adequate particle separation | Do not accept the impedance result without resolving overlap |
| Fibrin or clot | Unreliable count from partial consumption | Tube inspection and smear fibrin review | Reject or recollect under local procedure | Do not resolve a clotted specimen with a channel change |
| Evenly distributed, individually resolved low platelets | A potentially true low count | No clumps, fibrin, satellitism, or unresolved size overlap; concordant validated method when indicated | Apply the laboratory's verified low-result and urgent-communication procedure | A credible result is not excluded merely because it is low |
Knowledge checks
Reading and checks are open. Sign in only to save.
Knowledge check 1
Section status
Finish this section
Reading and checks are open. Sign in only to save.
The module finishes after every required section is marked done and every check in those sections is correct.